Candidate gene and genome-wide analyses are increasingly integrated to identify genetic variations influencing addiction. In the former, genes known to influence the pathogenesis or treatment of addictions are selected, for example, based on discoveries in animal pharmacobehavioral and genetic studies or based on what is known about the pharmacokinetics and pharmacodynamics of the drug. In genome-wide studies, the genome is interrogated in a hypothesis-free way.
